NO2800866T3 - - Google Patents
Info
- Publication number
- NO2800866T3 NO2800866T3 NO13700794A NO13700794A NO2800866T3 NO 2800866 T3 NO2800866 T3 NO 2800866T3 NO 13700794 A NO13700794 A NO 13700794A NO 13700794 A NO13700794 A NO 13700794A NO 2800866 T3 NO2800866 T3 NO 2800866T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26041—Use of virus, viral particle or viral elements as a vector
- C12N2770/26042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485955P | 2011-05-13 | 2011-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2800866T3 true NO2800866T3 (enExample) | 2018-04-14 |
Family
ID=47176093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13700794A NO2800866T3 (enExample) | 2011-05-13 | 2013-01-04 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9833504B2 (enExample) |
| EP (2) | EP2707480B1 (enExample) |
| JP (2) | JP6213461B2 (enExample) |
| CN (2) | CN103687942A (enExample) |
| AU (1) | AU2012255595A1 (enExample) |
| BR (2) | BR112013029144A2 (enExample) |
| CA (2) | CA2835972A1 (enExample) |
| DK (1) | DK2707480T3 (enExample) |
| MX (1) | MX2013013228A (enExample) |
| NO (1) | NO2800866T3 (enExample) |
| WO (2) | WO2012155261A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013029144A2 (pt) | 2011-05-13 | 2017-07-11 | Folia Biotech Inc | uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kit |
| US20160228541A1 (en) * | 2013-09-19 | 2016-08-11 | Alain Lamarre | Papaya mosaic virus and virus-like particles in cancer therapy |
| US11998594B2 (en) | 2014-04-02 | 2024-06-04 | Case Western Reserve University | Anti-cancer plant virus particles linked to HER2 antigens |
| WO2015153883A1 (en) * | 2014-04-02 | 2015-10-08 | Case Western Reserve University | Vaccination using plant virus particles linked to her2 antigens |
| MA40624A (fr) * | 2014-09-11 | 2016-03-17 | Cadila Healthcare Ltd | Antigènes supérieurs du papillomavirus présentant des propriétés immunologiques supérieures et vaccin les contenant |
| WO2016127262A1 (en) * | 2015-02-12 | 2016-08-18 | Folia Biotech Inc. | Multimerized orthomyxovirus nucleoprotein and uses thereof |
| GB201708709D0 (en) | 2017-06-01 | 2017-07-19 | Univ York | Virus like particle |
| MX385484B (es) * | 2017-06-28 | 2025-03-14 | Univ Mexico Nac Autonoma | Vlps derivadas de virus de planta con dsrna encapsidado y metodo de sintesis. |
| FR3106648B1 (fr) * | 2020-01-28 | 2022-05-27 | Arkema France | Structure multicouche pour le transport ou le stockage de l’hydrogene |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443969A (en) | 1992-10-29 | 1995-08-22 | Rutgers University | RNA packaging system |
| US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| DK1523329T3 (da) | 2002-07-05 | 2013-10-14 | Folia Biotech Inc | Viruspartikeladjuvant |
| JP2009513532A (ja) | 2003-07-10 | 2009-04-02 | サイトス バイオテクノロジー アーゲー | パッケージ化ウイルス様粒子 |
| ATE472336T1 (de) | 2003-10-22 | 2010-07-15 | Id Biomedical Corp Quebec | Zusammensetzungen und verfahren zur aktivierung der eigenen und allergischen immunität |
| WO2008058396A1 (en) * | 2006-11-15 | 2008-05-22 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines for influenza |
| US20100047264A1 (en) | 2006-11-15 | 2010-02-25 | Folia Biotech Inc. | Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof |
| US7799281B2 (en) | 2007-01-16 | 2010-09-21 | Festo Corporation | Flux concentrator for biomagnetic particle transfer device |
| JP2010516713A (ja) | 2007-01-26 | 2010-05-20 | フォーリア バイオテック インコーポレーテッド | 腸チフス菌および他の腸内細菌病原体に対するパパイアモザイクウィルスベースのワクチン |
| CA2742288A1 (en) | 2008-07-30 | 2010-02-04 | Folia Biotech Inc. | Multivalent vaccines based on papaya mosaic virus and uses thereof |
| WO2010030790A2 (en) | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| BR112013029144A2 (pt) | 2011-05-13 | 2017-07-11 | Folia Biotech Inc | uso de uma composição, método para estimular uma resposta imune inata em um indivíduo, método para proteger um indivíduo contra infecção microbiana, método para tratar uma infecção crônica ou recorrente e kit |
-
2012
- 2012-05-01 BR BR112013029144A patent/BR112013029144A2/pt not_active IP Right Cessation
- 2012-05-01 DK DK12785518.7T patent/DK2707480T3/da active
- 2012-05-01 JP JP2014509577A patent/JP6213461B2/ja not_active Expired - Fee Related
- 2012-05-01 AU AU2012255595A patent/AU2012255595A1/en not_active Abandoned
- 2012-05-01 EP EP12785518.7A patent/EP2707480B1/en not_active Not-in-force
- 2012-05-01 JP JP2014509576A patent/JP6093926B2/ja not_active Expired - Fee Related
- 2012-05-01 MX MX2013013228A patent/MX2013013228A/es not_active Application Discontinuation
- 2012-05-01 US US14/117,365 patent/US9833504B2/en active Active
- 2012-05-01 EP EP12786315.7A patent/EP2707027A4/en not_active Withdrawn
- 2012-05-01 BR BR112013029143A patent/BR112013029143A2/pt not_active IP Right Cessation
- 2012-05-01 CN CN201280022947.1A patent/CN103687942A/zh active Pending
- 2012-05-01 CA CA2835972A patent/CA2835972A1/en not_active Abandoned
- 2012-05-01 WO PCT/CA2012/050278 patent/WO2012155261A1/en not_active Ceased
- 2012-05-01 US US14/117,363 patent/US20140154288A1/en not_active Abandoned
- 2012-05-01 WO PCT/CA2012/050279 patent/WO2012155262A1/en not_active Ceased
- 2012-05-01 CA CA2835967A patent/CA2835967A1/en not_active Abandoned
- 2012-05-01 CN CN201280023824.XA patent/CN103648528A/zh active Pending
-
2013
- 2013-01-04 NO NO13700794A patent/NO2800866T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140255439A1 (en) | 2014-09-11 |
| CN103648528A (zh) | 2014-03-19 |
| US20140154288A1 (en) | 2014-06-05 |
| WO2012155262A1 (en) | 2012-11-22 |
| MX2013013228A (es) | 2013-12-12 |
| BR112013029143A2 (pt) | 2017-07-11 |
| BR112013029144A2 (pt) | 2017-07-11 |
| EP2707027A4 (en) | 2015-06-03 |
| AU2012255595A1 (en) | 2013-12-12 |
| US9833504B2 (en) | 2017-12-05 |
| DK2707480T3 (da) | 2017-11-13 |
| CN103687942A (zh) | 2014-03-26 |
| JP6093926B2 (ja) | 2017-03-15 |
| JP6213461B2 (ja) | 2017-10-18 |
| JP2014514350A (ja) | 2014-06-19 |
| EP2707027A1 (en) | 2014-03-19 |
| CA2835972A1 (en) | 2012-11-22 |
| EP2707480A1 (en) | 2014-03-19 |
| WO2012155261A1 (en) | 2012-11-22 |
| CA2835967A1 (en) | 2012-11-22 |
| EP2707480A4 (en) | 2015-01-07 |
| JP2014519817A (ja) | 2014-08-21 |
| EP2707480B1 (en) | 2017-08-02 |